Novel role for gabapentin in neuroprotection of central nervous system in streptozotocine-induced diabetic rats

Acta Pharmacologica Sinica

Volumn 26, Issue 4, 2005, Pages 417-422

  Baydas, Giyasettin ^a   Sonkaya, Ertugrul ^a   Tuzcu, Mehmet ^a   Yasar, Abdullah ^a   Donder, Emir ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Gabapentin; Glial fibrillary acidic protein; Lipid peroxidation; Neurotrophic protein S100beta; Phosphopyruvate hydratase

Indexed keywords

ALKENE DERIVATIVE; GABAPENTIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; MALONALDEHYDE; NEURON SPECIFIC ENOLASE; PROTEIN S100B; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; GLIA CELL; HIPPOCAMPUS; HYPERGLYCEMIA; IMMUNOBLOTTING; LIPID PEROXIDATION; MALE; NERVE CELL LESION; NERVE DEGENERATION; NEUROPATHY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PREDICTION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; UPREGULATION;

AMINES; ANIMALS; BRAIN; CYCLOHEXANECARBOXYLIC ACIDS; DIABETES MELLITUS, EXPERIMENTAL; GAMMA-AMINOBUTYRIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; PHOSPHOPYRUVATE HYDRATASE; RANDOM ALLOCATION; RATS; RATS, WISTAR; S100 PROTEINS;

EID: 16444365215     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00072.x     Document Type: Article

References (32)

1. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH. Cerebral function in diabetes mellitus. Diabetologia 1994; 37: 643-50.
2. Baydas G, Canatan H, Turkoglu A. Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus. J Pineal Res 2002; 32: 225-30.
3. Hawkins CL, Davies MJ. Generation and propagation of radical reactions on proteins. Biochim Biophys Acta 2001; 1504: 196-219.
4. Field MJ, McCleary S, Hughes J, Singh L. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 1999; 80: 391-8.
5. Su TZ, Lunney E, Campbell G, Oxender DL. Transport of gabapentin, a gamma-amino acid drug, by system 1 alpha-amino acid transporters: a comparative study in astrocytes, synaptosomes, and CHO cells. J Neurochem 1995; 64: 2125-31.
6. Lagreze WA, Müler-Valten R, Feuerstein TJ. The neuroprotective properties of gabapentin-lactam. Graef's Arch Clin Exp Ophthalmol 2001; 239: 845-9.
7. Buttner T, Lack B, Jager M, Wunsche W, Kuhn W, Muller T, et al. Serum levels of neuron-specific enolase and S-100 protein after single tonic-clonic seizures. J Neurol 1999; 246: 459-61.
8. Hatfield RH, McKernan RM. CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke model. Brain Res 1992; 577: 249-52.
9. Persson L, Hardemark HG, Gustafsson J, Rundstrom G, Mendel-Hartvig I, Essener T, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987; 18: 911-8.
10. Kligman D, Marshak DR. Purification and characterisation of a neurite extension factor from bovine brain. Proc Natl Acad Sci USA 1985; 82: 7136-9.
11. Heizmann CW, Fritz G, Schafer BW. S-100 proteins: structure, functions and pathology. Front Biosci 2002; 7: 1356-67.
12. Misler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-spesific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997; 28: 1956-60.
13. Liedtke W, Edelmann W, Bieri PL, Chiu FC, Cowan NJ, Kucherlapati R, et al. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 1996; 17: 607-15.
14. Kunkler PE, Kraig RP. Reactive astrocytosis from excitotoxic injury in hippocampal organ culture parallels that seen in vivo. J Cereb Blood Flow Metab 1997; 17: 26-43.
15. Baydas G, Reiter RJ, Yasar A, Tuzcu M, Akdemir I, Nedzvetskii VS. Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radic Biol Med 2003; 35: 797-804.
16. Baydas G, Reiter RJ, Nedzvetskii VS, Yasar A, Tuzcu M, Ozveren F, et al. Melatonin protects the central nervous system of rats against toluene-containing thinner intoxication by reducing reactive gliosis. Toxicol Lett 2003; 137: 169-74.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
18. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 82: 70-7.
19. Fano G, Mariggio MA, Angelella P, Nicoletti I, Antonica A, Fulle S, et al. The S-100 protein causes an increase of intracellular calcium and death of PC12 cells. Neuroscience 1993; 53: 919-25.
20. Donate R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001; 33: 637-68.
21. Rothstein JD, Kuncl RW. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 1995; 65: 643-51.
22. Ercel E, Baydas G, Akyol A, Eksioglu E, Canpolat L. The effect of vitamin E on the sciatic nerve lipid peroxidation in streptozotocin induced diabetes mellitus. Biomed Res 1999; 10: 95-101.
23. Guyot LL, Diaz FG, O'Regan MH, Song D, Phillis JW. The effect of topical insulin on the release of excitotoxic and other amino acids from the rat cerebral cortex during streptozotocin-induced hyperglycemic ischemia. Brain Res 2000; 872: 29-36.
24. Malcangio M, Tomlinson DR. A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain 1998; 76: 151-7.
25. Petroff OA, Rothman DL, Behor KL, Lamoureux D, Mattson RH. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol 1996; 39: 95-9.
26. Cutrer FM. Antiepileptic drugs: how they work in headache. Headache 2001; 41: S3-10.
27. Petroff OA, Hyder F, Rothman DL, Mattson RH. Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients. Epilepsia 2000; 41: 675-80.
28. Shimoyama M, Shimoyama N, Hori Y. Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain 2000; 85: 405-14.
29. Gupta M, Singh J, Sood S, Arora B. Mechanism of antinociceptive effect of nimodipine in experimental diabetic neuropathic pain. Methods Find Exp Clin Pharmacol 2003; 25: 49-52.
30. Kaneko K, Nakamura A, Yoshida K, Kametani F, Higuchi K, Ikeda S. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radic Res 2002; 36: 303-6.
31. Baydas G, Nedzvetskii VS, Tuzcu M, Yasar A, Kirichenko SV. Increase of glial fibrillary acidic protein and S-100 in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur J Pharmacol 2003; 462: 67-71.
32. 2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002; 42: 229-36.